Total Payments
$781.21
2024 Payments
$140.48
Companies
9
Transactions
31
Medicare Patients
5,350
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$781.21 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $781.21 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Pharma plc | $259.74 | 20 | $0 (2018) |
| MERZ NORTH AMERICA, INC. | $140.48 | 2 | $0 (2024) |
| Novo Nordisk Inc | $113.58 | 1 | $0 (2019) |
| Allergan Inc. | $97.95 | 1 | $0 (2019) |
| Horizon Therapeutics plc | $62.82 | 3 | $0 (2019) |
| Tenex Health Inc. | $56.48 | 1 | $0 (2018) |
| ABBVIE INC. | $18.92 | 1 | $0 (2023) |
| Lilly USA, LLC | $16.67 | 1 | $0 (2017) |
| PFIZER INC. | $14.57 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140.48 | 2 | MERZ NORTH AMERICA, INC. ($140.48) |
| 2023 | $18.92 | 1 | ABBVIE INC. ($18.92) |
| 2019 | $274.35 | 5 | Novo Nordisk Inc ($113.58) |
| 2018 | $147.47 | 6 | Horizon Pharma plc ($76.42) |
| 2017 | $199.99 | 17 | Horizon Pharma plc ($183.32) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $108.15 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Dermatology | ||||||
| 11/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $97.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2019 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: DUEXIS | ||||||
| 07/08/2019 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: DUEXIS | ||||||
| 05/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $113.58 | General |
| Category: Diabetes | ||||||
| 04/05/2019 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: DUEXIS | ||||||
| 12/27/2018 | Tenex Health Inc. | — | Food and Beverage | In-kind items and services | $56.48 | General |
| Category: Orthopedic | ||||||
| 06/29/2018 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: PENNSAID | ||||||
| 06/07/2018 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: DUEXIS | ||||||
| 05/25/2018 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: DUEXIS | ||||||
| 02/27/2018 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: DUEXIS | ||||||
| 01/23/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/15/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: DUEXIS | ||||||
| 12/08/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: DUEXIS | ||||||
| 09/14/2017 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: PENNSAID | ||||||
| 09/05/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: DUEXIS | ||||||
| 08/28/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: DUEXIS | ||||||
| 06/19/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: DUEXIS | ||||||
| 05/31/2017 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: VIMOVO | ||||||
| 05/26/2017 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: PENNSAID | ||||||
| 04/25/2017 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Bone Muscle Joint | ||||||
| 03/22/2017 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: PENNSAID | ||||||
| 02/28/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: DUEXIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,539 | 21,225 | $1.2M | $299,003 |
| 2022 | 15 | 2,006 | 25,826 | $1.9M | $499,751 |
| 2021 | 15 | 1,563 | 27,620 | $1.9M | $518,916 |
| 2020 | 9 | 242 | 2,791 | $188,396 | $51,160 |
Total Patients
5,350
Total Services
77,462
Medicare Billing
$1.4M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2023 | 109 | 15,900 | $405,450 | $90,171 | 22.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 136 | 739 | $233,524 | $65,685 | 28.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 140 | 746 | $146,962 | $37,954 | 25.8% |
| 27369 | Injection of contrast for imaging of knee joint | Office | 2023 | 120 | 169 | $76,219 | $22,837 | 30.0% |
| 97813 | Acupuncture with electrical stimulation, initial 15 minutes | Office | 2023 | 66 | 599 | $80,865 | $21,141 | 26.1% |
| 97814 | Acupuncture with electrical stimulation, each additional 15 minutes | Office | 2023 | 66 | 599 | $65,890 | $17,276 | 26.2% |
| 73580 | Review by radiologist of knee joint image | Office | 2023 | 120 | 169 | $67,262 | $15,611 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 127 | 127 | $43,166 | $10,771 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 103 | $25,342 | $6,971 | 27.5% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 31 | 92 | $21,804 | $5,587 | 25.6% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 75 | 82 | $8,364 | $1,942 | 23.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 62 | 65 | $4,615 | $1,077 | 23.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 25 | $3,550 | $1,006 | 28.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 121 | 674 | $4,044 | $557.73 | 13.8% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 149 | 904 | $22,600 | $321.12 | 1.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 106 | 232 | $464.00 | $95.55 | 20.6% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2022 | 110 | 16,600 | $835,882 | $211,911 | 25.4% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 179 | 996 | $314,736 | $90,967 | 28.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 184 | 1,007 | $198,379 | $52,680 | 26.6% |
| 27369 | Injection of contrast for imaging of knee joint | Office | 2022 | 179 | 265 | $119,515 | $36,085 | 30.2% |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2022 | 38 | 3,750 | $146,308 | $32,132 | 22.0% |
| 73580 | Review by radiologist of knee joint image | Office | 2022 | 177 | 270 | $107,460 | $31,493 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 179 | 179 | $61,576 | $14,275 | 23.2% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2022 | 37 | 176 | $42,180 | $10,565 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 155 | $36,270 | $10,391 | 28.6% |
About Dr. Thomas Phipps, M.D
Dr. Thomas Phipps, M.D is a Sports Medicine healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1558513564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Phipps, M.D has received a total of $781.21 in payments from pharmaceutical and medical device companies, with $140.48 received in 2024. These payments were reported across 31 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($781.21).
As a Medicare-enrolled provider, Phipps has provided services to 5,350 Medicare beneficiaries, totaling 77,462 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Location Orlando, FL
- Active Since 10/21/2008
- Last Updated 10/30/2019
- Taxonomy Code 207RS0010X
- Entity Type Individual
- NPI Number 1558513564
Products in Payments
- DUEXIS (Drug) $260.36
- Xeomin (Biological) $140.48
- Ozempic (Drug) $113.58
- LINZESS (Drug) $97.95
- PENNSAID (Drug) $44.62
- UBRELVY (Drug) $18.92
- VIMOVO (Drug) $17.58
- FORTEO (Drug) $16.67
- CHANTIX (Drug) $14.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Orlando
Dr. Abhishek Kannan, M.d, M.D
Sports Medicine — Payments: $27,923
Sports Medicine $27,923
Dr. Luke Oh, M.d, M.D
Sports Medicine — Payments: $6,866
Sports Medicine $6,866
Dr. Bryan Reuss, Md, MD
Sports Medicine — Payments: $5,953
Sports Medicine $5,953
Mr. Thomas Winters, Md, MD
Sports Medicine — Payments: $4,254
Sports Medicine $4,254
Kathleen Buran, Md, MD
Sports Medicine — Payments: $2,618
Sports Medicine $2,618
John Sanderson, Do, DO
Sports Medicine — Payments: $1,570
Sports Medicine $1,570